Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway

Published:2024-04 Issue:4 Volume:43 Page:114065
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zhu Meng,Han Yingli,Gu Tianning,Wang Rui,Si Xiaohui,Kong Delin,Zhao Peng,Wang Xiujian,Li Jinxin,Zhai Xingyuan,Yu Zebin,Lu Huan,Li Jingyi,Huang He,Qian Pengxu^ORCID

Funder

National Natural Science Foundation of China

Zhejiang Province Natural Science Foundation

National Key Research and Development Program of China

Publisher

Elsevier BV

Reference102 articles.

1. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N. Engl. J. Med.,2011

2. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

3. Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy;Cappell;J. Clin. Oncol.,2020

4. Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy;Chong;N. Engl. J. Med.,2021

5. Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells;Melenhorst;Nature,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

2. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods;Pharmaceuticals;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP